down arrow

Lupin

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
1,980.00
58.7 (3.06%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.22 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,951.252,016.55

52 Week

1,493.752,403.45
Valuation
Technical
Day's Volume

CASH

6.22 lacs (-54.70%) Volume

Shareholding (Dec 2024)

FII

22.04%

Held by 861 FIIs

DII

24.74%

Held by 70 DIIs

Promoter

46.95%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Healthy long term growth as Operating profit has grown by an annual rate 16.86%

 
3

The company has declared Positive results for the last 9 consecutive quarters

4

Stock is technically in a Bearish range

5

With ROE of 16.8, it has a Attractive valuation with a 5.6 Price to Book Value

6

High Institutional Holdings at 46.79%

7

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 90,400 Cr (Large Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.42%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

16.79%

stock-summary
Price to Book

5.61

Revenue and Profits (1 Year):
Net Sales:
5,768 Cr
(Quarterly Results - Dec 2024)
Net Profit:
855 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.42%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-10.96%
0%
-10.96%
1 Year
23.33%
0.49%
23.82%
2 Years
199.84%
1.64%
201.48%
3 Years
152.2%
2.30%
154.5%
4 Years
83.4%
1.89%
85.29%
5 Years
151.35%
3.19%
154.54%

Latest dividend: 8 per share ex-dividend date: Jul-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.14%
EBIT Growth (5y)
16.86%
EBIT to Interest (avg)
4.74
Debt to EBITDA (avg)
3.17
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
20.04%
Dividend Payout Ratio
19.04%
Pledged Shares
0
Institutional Holding
46.79%
ROCE (avg)
7.82%
ROE (avg)
5.64%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
33
Price to Book Value
5.61
EV to EBIT
23.85
EV to EBITDA
17.89
EV to Capital Employed
5.46
EV to Sales
4.01
PEG Ratio
0.51
Dividend Yield
0.42%
ROCE (Latest)
21.01%
ROE (Latest)
16.79%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 35 Schemes (16.92%)

FIIs

Held by 861 FIIs (22.04%)

Promoter with highest holding

Lupin Investments Pvt Ltd (45.41%)

Highest Public shareholder

Hdfc Trustee Company Ltd-hdfc Balanced Advantage Fund (3.36%)

Individual Investors Holdings

5.17%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.67% vs 1.29% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.30% vs 6.40% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,767.71",
          "val2": "5,672.73",
          "chgp": "1.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,355.90",
          "val2": "1,340.36",
          "chgp": "1.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "66.89",
          "val2": "70.87",
          "chgp": "-5.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "855.16",
          "val2": "852.63",
          "chgp": "0.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.13%",
          "val2": "24.38%",
          "chgp": "-0.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 14.42% vs 24.88% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 75.59% vs 2,217.17% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,273.06",
          "val2": "9,852.62",
          "chgp": "14.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,581.33",
          "val2": "1,775.02",
          "chgp": "45.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "138.88",
          "val2": "166.31",
          "chgp": "-16.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,653.94",
          "val2": "941.93",
          "chgp": "75.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.44%",
          "val2": "18.33%",
          "chgp": "5.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.23% vs 23.24% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 61.35% vs 701.08% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17,040.77",
          "val2": "15,050.03",
          "chgp": "13.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,937.23",
          "val2": "2,812.96",
          "chgp": "39.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "205.77",
          "val2": "240.32",
          "chgp": "-14.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,509.10",
          "val2": "1,555.05",
          "chgp": "61.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.10%",
          "val2": "18.69%",
          "chgp": "4.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 20.25% vs 1.44% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 345.15% vs 128.15% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20,010.82",
          "val2": "16,641.66",
          "chgp": "20.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,810.52",
          "val2": "1,798.12",
          "chgp": "111.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "311.61",
          "val2": "274.30",
          "chgp": "13.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,914.48",
          "val2": "430.08",
          "chgp": "345.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.39%",
          "val2": "11.05%",
          "chgp": "8.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
5,767.71
5,672.73
1.67%
Operating Profit (PBDIT) excl Other Income
1,355.90
1,340.36
1.16%
Interest
66.89
70.87
-5.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
855.16
852.63
0.30%
Operating Profit Margin (Excl OI)
24.13%
24.38%
-0.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.67% vs 1.29% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 0.30% vs 6.40% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
11,273.06
9,852.62
14.42%
Operating Profit (PBDIT) excl Other Income
2,581.33
1,775.02
45.43%
Interest
138.88
166.31
-16.49%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,653.94
941.93
75.59%
Operating Profit Margin (Excl OI)
23.44%
18.33%
5.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 14.42% vs 24.88% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 75.59% vs 2,217.17% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
17,040.77
15,050.03
13.23%
Operating Profit (PBDIT) excl Other Income
3,937.23
2,812.96
39.97%
Interest
205.77
240.32
-14.38%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,509.10
1,555.05
61.35%
Operating Profit Margin (Excl OI)
23.10%
18.69%
4.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.23% vs 23.24% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 61.35% vs 701.08% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
20,010.82
16,641.66
20.25%
Operating Profit (PBDIT) excl Other Income
3,810.52
1,798.12
111.92%
Interest
311.61
274.30
13.60%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,914.48
430.08
345.15%
Operating Profit Margin (Excl OI)
19.39%
11.05%
8.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 20.25% vs 1.44% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 345.15% vs 128.15% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Lupin Ltd. stock-summary
stock-summary
Lupin Ltd.
Large Cap
Pharmaceuticals & Drugs
Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
Company Coordinates stock-summary
Company Details
Kalpataru Inspire 3rd Floor, Off Western Exp HW Santacruz-E Mumbai Maharashtra : 400055
stock-summary
Tel: 91-22-6640 2323
stock-summary
http://www.lupin.com
stock-summary
info@lupin.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."